Zota Health Care LImited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more
Zota Health Care LImited - Asset Resilience Ratio
Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹14.87 Million | 0.34% |
| Short-term Investments | ₹14.87 Million | 0.34% |
| Total Liquid Assets | ₹29.74 Million | 0.68% |
Asset Resilience Insights
- Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Zota Health Care LImited Industry Peers by Asset Resilience Ratio
Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Zota Health Care LImited (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.68% | ₹29.74 Million | ₹4.39 Billion | +0.39pp |
| 2024-03-31 | 0.29% | ₹6.56 Million | ₹2.28 Billion | -1.01pp |
| 2023-03-31 | 1.29% | ₹20.46 Million | ₹1.58 Billion | -1.96pp |
| 2022-03-31 | 3.25% | ₹45.22 Million | ₹1.39 Billion | +0.16pp |
| 2021-03-31 | 3.09% | ₹26.39 Million | ₹854.69 Million | +1.26pp |
| 2020-03-31 | 1.83% | ₹16.21 Million | ₹884.79 Million | +1.83pp |
| 2019-03-31 | 0.00% | ₹120.00 | ₹896.07 Million | +0.22pp |
| 2018-03-31 | -0.22% | ₹-2.00 Million | ₹917.94 Million | +0.03pp |
| 2016-03-31 | -0.24% | ₹-1.08 Million | ₹440.52 Million | -- |